Invention Grant
US08686022B2 7-(piperazine-1-ymethyl)-1H-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 MAP kinase inhibitors for the treatment of respiratory diseases
有权
7-（哌嗪-1-基甲基）-1H-吲哚-2-羧酸（苯基） - 酰胺衍生物和相关化合物作为治疗呼吸道疾病的p38 MAP激酶抑制剂
- Patent Title: 7-(piperazine-1-ymethyl)-1H-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 MAP kinase inhibitors for the treatment of respiratory diseases
- Patent Title (中): 7-（哌嗪-1-基甲基）-1H-吲哚-2-羧酸（苯基） - 酰胺衍生物和相关化合物作为治疗呼吸道疾病的p38 MAP激酶抑制剂
-
Application No.: US13060504Application Date: 2009-08-26
-
Publication No.: US08686022B2Publication Date: 2014-04-01
- Inventor: Holger Wagner , Birgit Jung , Frank Himmelsbach , Rolf Goeggel , Georg Dahmann
- Applicant: Holger Wagner , Birgit Jung , Frank Himmelsbach , Rolf Goeggel , Georg Dahmann
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- Priority: EP08163526 20080902
- International Application: PCT/EP2009/061025 WO 20090826
- International Announcement: WO2010/026096 WO 20100311
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K31/405
Abstract:
The present invention provides compounds according to general formula (I) which are proposed for the treatment of respiratory complaints, particularly asthma and COPD.
Public/Granted literature
Information query
